Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 962

1.

The Maudsley environmental risk score for psychosis.

Vassos E, Sham P, Kempton M, Trotta A, Stilo SA, Gayer-Anderson C, Di Forti M, Lewis CM, Murray RM, Morgan C.

Psychol Med. 2019 Sep 19:1-8. doi: 10.1017/S0033291719002319. [Epub ahead of print]

PMID:
31535606
2.

Non-Genetic Factors in Schizophrenia.

Stilo SA, Murray RM.

Curr Psychiatry Rep. 2019 Sep 14;21(10):100. doi: 10.1007/s11920-019-1091-3. Review.

3.

Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.

Smart SE, Kępińska AP, Murray RM, MacCabe JH.

Psychol Med. 2019 Aug 29:1-10. doi: 10.1017/S0033291719002083. [Epub ahead of print]

PMID:
31462334
4.

The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder.

de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, Caseras X, Castro-Fornieles J, Chen Q, Chung Y, De la Serna E, Di Giorgio A, Doucet GE, Eker MC, Erk S, Fears SC, Foley SF, Frangou S, Frankland A, Fullerton JM, Glahn DC, Goghari VM, Goldman AL, Gonul AS, Gruber O, de Haan L, Hajek T, Hawkins EL, Heinz A, Hillegers MHJ, Hulshoff Pol HE, Hultman CM, Ingvar M, Johansson V, Jönsson EG, Kane F, Kempton MJ, Koenis MMG, Kopecek M, Krabbendam L, Krämer B, Lawrie SM, Lenroot RK, Marcelis M, Marsman JC, Mattay VS, McDonald C, Meyer-Lindenberg A, Michielse S, Mitchell PB, Moreno D, Murray RM, Mwangi B, Najt P, Neilson E, Newport J, van Os J, Overs B, Ozerdem A, Picchioni MM, Richter A, Roberts G, Aydogan AS, Schofield PR, Simsek F, Soares JC, Sugranyes G, Toulopoulou T, Tronchin G, Walter H, Wang L, Weinberger DR, Whalley HC, Yalin N, Andreassen OA, Ching CRK, van Erp TGM, Turner JA, Jahanshad N, Thompson PM, Kahn RS, van Haren NEM.

Biol Psychiatry. 2019 Oct 1;86(7):545-556. doi: 10.1016/j.biopsych.2019.03.985. Epub 2019 Jun 13.

5.

Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.

Dazzan P, Lappin JM, Heslin M, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Morgan C.

Psychol Med. 2019 Jul 31:1-11. doi: 10.1017/S0033291719001399. [Epub ahead of print]

PMID:
31364523
6.

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP , Murray RM, Di Forti M.

Schizophr Bull. 2019 Jul 29. pii: sbz077. doi: 10.1093/schbul/sbz077. [Epub ahead of print]

PMID:
31361020
7.

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study.

Gaughran F, Stahl D, Stringer D, Hopkins D, Atakan Z, Greenwood K, Patel A, Smith S, Gardner-Sood P, Lally J, Heslin M, Stubbs B, Bonaccorso S, Kolliakou A, Howes O, Taylor D, Forti MD, David AS, Murray RM, Ismail K; IMPACT team.

Br J Psychiatry. 2019 Jul 26:1-8. doi: 10.1192/bjp.2019.159. [Epub ahead of print]

PMID:
31347480
8.

Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study.

Misra S, Gelaye B, Koenen KC, Williams DR, Borba CPC, Quattrone D, Di Forti M, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB; EU-GEI WP2 Group, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C.

J Clin Med. 2019 Jul 23;8(7). pii: E1081. doi: 10.3390/jcm8071081.

9.
10.

Hard Limits and Performance Tradeoffs in a Class of Antithetic Integral Feedback Networks.

Olsman N, Baetica AA, Xiao F, Leong YP, Murray RM, Doyle JC.

Cell Syst. 2019 Jul 24;9(1):49-63.e16. doi: 10.1016/j.cels.2019.06.001. Epub 2019 Jul 3.

PMID:
31279505
11.

IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.

Ferraro L, Murray RM, Di Forti M, Quattrone D, Tripoli G, Sideli L, La Barbera D, La Cascia C.

Schizophr Res. 2019 Aug;210:81-88. doi: 10.1016/j.schres.2019.06.004. Epub 2019 Jul 2.

PMID:
31272907
12.

Should the supply of cannabis be legalised now?

Meacher M, Nutt D, Liebling J, Murray RM, Gridley A.

BMJ. 2019 Jul 3;366:l4473. doi: 10.1136/bmj.l4468. No abstract available.

PMID:
31270061
13.

Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.

Zanelli J, Mollon J, Sandin S, Morgan C, Dazzan P, Pilecka I, Reis Marques T, David AS, Morgan K, Fearon P, Doody GA, Jones PB, Murray RM, Reichenberg A.

Am J Psychiatry. 2019 Oct 1;176(10):811-819. doi: 10.1176/appi.ajp.2019.18091088. Epub 2019 Jul 1.

PMID:
31256609
14.

Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition.

Siriyong T, Murray RM, Bidgood LE, Young SA, Wright F, Parcell BJ, Voravuthikunchai SP, Coote PJ.

Sci Rep. 2019 Jun 24;9(1):9098. doi: 10.1038/s41598-019-45550-z.

15.

Corrigendum to "Dysconnectivity of neurocognitive networks at rest in very-preterm born adults" [NeuroImage: Clinical 4 (2014) 352-365].

White T, Symington I, Castellanos NP, Brittain PJ, Walsh SF, Nam KW, Sato JR, Allin MPG, Shergill SS, Murray RM, Williams SCR, Nosarti C.

Neuroimage Clin. 2019;23:101901. doi: 10.1016/j.nicl.2019.101901. Epub 2019 Jun 20. No abstract available.

16.

The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.

Richards AL, Pardiñas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, Legge SE, Savage JE, Agartz I, Andreassen OA, Blokland GAM, Corvin A, Cosgrove D, Degenhardt F, Djurovic S, Espeseth T, Ferraro L, Gayer-Anderson C, Giegling I, van Haren NE, Hartmann AM, Hubert JJ, Jönsson EG, Konte B, Lennertz L, Olde Loohuis LM, Melle I, Morgan C, Morris DW, Murray RM, Nyman H, Ophoff RA; GROUP Investigators, van Os J; EUGEI WP2 Group; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Petryshen TL, Quattrone D, Rietschel M, Rujescu D, Rutten BPF, Streit F, Strohmaier J, Sullivan PF, Sundet K, Wagner M, Escott-Price V, Owen MJ, Donohoe G, O'Donovan MC, Walters JTR.

Schizophr Bull. 2019 Jun 17. pii: sbz061. doi: 10.1093/schbul/sbz061. [Epub ahead of print]

PMID:
31206164
17.

Correction: Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala.

O'Daly OG, Joyce D, Tracy DK, Azim A, Stephan KE, Murray RM, Shergill SS.

PLoS One. 2019 Jun 12;14(6):e0218478. doi: 10.1371/journal.pone.0218478. eCollection 2019.

18.

Tobacco smoking and nicotine dependence in first episode and established psychosis.

Lally J, Spaducci G, Gardner-Sood P, Atakan Z, Greenwood K, Di Forti M, Ismail K, Murphy KC, Smith S, McNeill A, Murray RM, Gaughran F.

Asian J Psychiatr. 2019 Jun;43:125-131. doi: 10.1016/j.ajp.2019.05.002. Epub 2019 May 4.

PMID:
31132542
19.

High-potency cannabis and incident psychosis: correcting the causal assumption - Authors' reply.

Di Forti M, Morgan C, Selten JP, Lynskey M, Murray RM.

Lancet Psychiatry. 2019 Jun;6(6):466-467. doi: 10.1016/S2215-0366(19)30176-2. No abstract available.

PMID:
31122474
20.

Differential gene expression analysis in blood of first episode psychosis patients.

Leirer DJ, Iyegbe CO, Di Forti M, Patel H, Carra E, Fraietta S, Colizzi M, Mondelli V, Quattrone D, Lally J, Ajnakina O, Lee SH, Curtis CJ, Breen G, Pariante C, Aitchison K, Dazzan P, Murray RM, Dobson RJB, Newhouse SJ.

Schizophr Res. 2019 Jul;209:88-97. doi: 10.1016/j.schres.2019.05.011. Epub 2019 May 19.

21.

The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells.

Duarte RRR, Bachtel ND, Côtel MC, Lee SH, Selvackadunco S, Watson IA, Hovsepian GA, Troakes C, Breen GD, Nixon DF, Murray RM, Bray NJ, Eleftherianos I, Vernon AC, Powell TR, Srivastava DP.

Biol Psychiatry. 2019 Jul 15;86(2):120-130. doi: 10.1016/j.biopsych.2019.03.977. Epub 2019 Mar 30.

22.

Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studies.

Ajnakina O, Stubbs B, Francis E, Gaughran F, David AS, Murray RM, Lally J.

Psychol Med. 2019 May 6:1-11. doi: 10.1017/S0033291719000904. [Epub ahead of print]

PMID:
31057129
23.

Verbal Fluency Is Affected by Altered Brain Lateralization in Adults Who Were Born Very Preterm.

Tseng CJ, Froudist-Walsh S, Kroll J, Karolis V, Brittain PJ, Palamin N, Clifton H, Counsell SJ, Williams SCR, Murray RM, Nosarti C.

eNeuro. 2019 Apr 15;6(2). pii: ENEURO.0274-18.2018. doi: 10.1523/ENEURO.0274-18.2018. eCollection 2019 Mar-Apr.

24.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.

Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.

25.

Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence.

Vieira S, Gong QY, Pinaya WHL, Scarpazza C, Tognin S, Crespo-Facorro B, Tordesillas-Gutierrez D, Ortiz-García V, Setien-Suero E, Scheepers FE, Van Haren NEM, Marques TR, Murray RM, David A, Dazzan P, McGuire P, Mechelli A.

Schizophr Bull. 2019 Feb 27. pii: sby189. doi: 10.1093/schbul/sby189. [Epub ahead of print]

PMID:
30809667
26.

Construction of Incoherent Feedforward Loop Circuits in a Cell-Free System and in Cells.

Guo S, Murray RM.

ACS Synth Biol. 2019 Mar 15;8(3):606-610. doi: 10.1021/acssynbio.8b00493. Epub 2019 Mar 6.

PMID:
30790525
27.

Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study.

Luo Q, Chen Q, Wang W, Desrivières S, Quinlan EB, Jia T, Macare C, Robert GH, Cui J, Guedj M, Palaniyappan L, Kherif F, Banaschewski T, Bokde ALW, Büchel C, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Artiges E, Paillère-Martinot ML, Nees F, Orfanos DP, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Callicott JH, Mattay VS, Pausova Z, Dartigues JF, Tzourio C, Crivello F, Berman KF, Li F, Paus T, Weinberger DR, Murray RM, Schumann G, Feng J; IMAGEN consortium.

JAMA Psychiatry. 2019 Apr 1;76(4):435-445. doi: 10.1001/jamapsychiatry.2018.4126.

28.

'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!

Ajnakina O, David AS, Murray RM.

Psychol Med. 2018 Dec 26:1-6. doi: 10.1017/S0033291718003859. [Epub ahead of print]

PMID:
30585562
29.

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial.

Lally J, Watkins R, Nash S, Shetty H, Gardner-Sood P, Smith S, Murray RM, Gaughran F.

Front Psychiatry. 2018 Dec 4;9:654. doi: 10.3389/fpsyt.2018.00654. eCollection 2018.

30.

Assessing cross-national invariance of the Community Assessment of Psychic Experiences (CAPE).

Pignon B, Peyre H, Ferchiou A, van Os J, Rutten BPF, Murray RM, Morgan C, Leboyer M, Schürhoff F, Szöke A; EU-GEI WP2 Group Author.

Psychol Med. 2018 Dec 5:1-8. doi: 10.1017/S0033291718003574. [Epub ahead of print]

PMID:
30514407
31.

Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study.

Rodriguez V, Ajnakina O, Stilo SA, Mondelli V, Marques TR, Trotta A, Quattrone D, Gardner-Sood P, Colizzi M, Wiffen BD, Dazzan P, Di Forti M, Falcone MA, David AS, Murray RM.

Psychol Med. 2019 Oct;49(13):2256-2266. doi: 10.1017/S0033291718003197. Epub 2018 Nov 5.

PMID:
30392491
32.

Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study.

Kravariti E, Demjaha A, Zanelli J, Ibrahim F, Wise C, MacCabe JH, Reichenberg A, Pilecka I, Morgan K, Fearon P, Morgan C, Doody GA, Donoghue K, Jones PB, Kaçar AŞ, Dazzan P, Lappin J, Murray RM.

Psychol Med. 2019 Sep;49(12):2100-2110. doi: 10.1017/S0033291718002957. Epub 2018 Oct 23.

33.

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma HE, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Kirkbride JB, Richards AL, O'Donovan MC, Sham PC, Vassos E, Rutten BP, van Os J, Morgan C, Lewis CM, Murray RM, Reininghaus U.

Psychol Med. 2019 Jun;49(8):1378-1391. doi: 10.1017/S0033291718002131. Epub 2018 Oct 4.

34.

Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression.

Lopez-Morinigo JD, Di Forti M, Ajnakina O, Wiffen BD, Morgan K, Doody GA, Jones PB, Ayesa-Arriola R, Canal-Rivero M, Crespo-Facorro B, Murray RM, Dazzan P, Morgan C, Dutta R, David AS.

Schizophr Res. 2019 Feb;204:80-89. doi: 10.1016/j.schres.2018.09.016. Epub 2018 Sep 22.

PMID:
30253893
35.

Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis.

Nettis MA, Pergola G, Kolliakou A, O'Connor J, Bonaccorso S, David A, Gaughran F, Di Forti M, Murray RM, Marques TR, Blasi G, Bertolino A, Pariante CM, Dazzan P, Mondelli V.

Psychoneuroendocrinology. 2019 Jan;99:145-153. doi: 10.1016/j.psyneuen.2018.09.005. Epub 2018 Sep 8.

PMID:
30243054
36.

Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study.

Lally J, Ajnakina O, Singh N, Gardner-Sood P, Stubbs B, Stringer D, Di Forti M, David AS, Smith S, Murray RM, Howes OD, Gaughran F.

Schizophr Res. 2019 Feb;204:381-388. doi: 10.1016/j.schres.2018.08.011. Epub 2018 Aug 25.

PMID:
30154029
37.

Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients.

Ajnakina O, Trotta A, Forti MD, Stilo SA, Kolliakou A, Gardner-Sood P, Lopez-Morinigo J, Gaughran F, David AS, Dazzan P, Pariante C, Mondelli V, Murray RM, Fisher HL.

Psychiatry Res. 2018 Nov;269:199-206. doi: 10.1016/j.psychres.2018.08.054. Epub 2018 Aug 17.

PMID:
30153597
38.

Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis.

Cullen AE, Holmes S, Pollak TA, Blackman G, Joyce DW, Kempton MJ, Murray RM, McGuire P, Mondelli V.

Biol Psychiatry. 2019 Jan 1;85(1):35-48. doi: 10.1016/j.biopsych.2018.06.016. Epub 2018 Jun 28.

39.

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.

Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M; Genetic Risk and Outcome of Psychosis (GROUP) consortium, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, Lin K, McDonald C, McIntosh AM, McQuillin A, Picchioni M, Rujescu D, Shaikh M, Toulopoulou T, Os JV, Vassos E, Walshe M, Powell J, Lewis CM, Murray RM, Bramon E.

Br J Psychiatry. 2018 Sep;213(3):535-541. doi: 10.1192/bjp.2018.89.

40.

On-chip membrane protein cell-free expression enables development of a direct binding assay: A curious case of potassium channel KcsA-Kv1.3.

Vaish A, Guo S, Murray RM, Grandsard PJ, Chen Q.

Anal Biochem. 2018 Sep 1;556:70-77. doi: 10.1016/j.ab.2018.06.018. Epub 2018 Jun 21.

PMID:
29936096
41.

Is the grass greener for those at risk of psychosis?

Murray RM.

Schizophr Res. 2018 Nov;201:35-36. doi: 10.1016/j.schres.2018.04.041. Epub 2018 Jun 18. No abstract available.

PMID:
29914789
42.

Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics.

Murray RM, Di Forti M.

World Psychiatry. 2018 Jun;17(2):161-162. doi: 10.1002/wps.20517. No abstract available.

43.

Cortical thickness correlates of minor neurological signs in patients with first episode psychosis.

Ciufolini S, Ponteduro MF, Reis-Marques T, Taylor H, Mondelli V, Pariante CM, Bonaccorso S, Chan R, Simmons A, David A, Di Forti M, Murray RM, Dazzan P.

Schizophr Res. 2018 Oct;200:104-111. doi: 10.1016/j.schres.2018.05.005. Epub 2018 May 18.

PMID:
29785932
44.

Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse.

Ciufolini S, Gayer-Anderson C, Fisher HL, Marques TR, Taylor H, Di Forti M, Zunszain P, Morgan C, Murray RM, Pariante CM, Dazzan P, Mondelli V.

Schizophr Res. 2019 Mar;205:38-44. doi: 10.1016/j.schres.2018.05.002. Epub 2018 May 24.

PMID:
29776641
45.

Single Day Construction of Multigene Circuits with 3G Assembly.

Halleran AD, Swaminathan A, Murray RM.

ACS Synth Biol. 2018 May 18;7(5):1477-1480. doi: 10.1021/acssynbio.8b00060. Epub 2018 May 7.

PMID:
29715010
46.

Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.

Trotta A, Iyegbe C, Yiend J, Dazzan P, David AS, Pariante C, Mondelli V, Colizzi M, Murray RM, Di Forti M, Fisher HL.

Schizophr Res. 2019 Mar;205:51-57. doi: 10.1016/j.schres.2018.04.010. Epub 2018 Apr 10.

PMID:
29653893
47.

The antipsychotic landscape: dopamine and beyond.

Morrison PD, Murray RM.

Ther Adv Psychopharmacol. 2018 Apr;8(4):127-135. doi: 10.1177/2045125317752915. Epub 2018 Jan 23. Review.

48.

Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.

Lappin JM, Heslin M, Lomas B, Jones PB, Doody GA, Reininghaus UA, Croudace T, Craig T, Fearon P, Murray RM, Dazzan P, Morgan C.

Schizophr Res. 2018 Sep;199:341-345. doi: 10.1016/j.schres.2018.03.014. Epub 2018 Mar 20.

PMID:
29571751
49.

Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders.

Scheffler F, Kilian S, Chiliza B, Asmal L, Phahladira L, du Plessis S, Kidd M, Murray RM, Di Forti M, Seedat S, Emsley R.

Schizophr Res. 2018 Sep;199:90-95. doi: 10.1016/j.schres.2018.02.050. Epub 2018 Mar 6.

PMID:
29519756
50.

Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia.

Ajnakina O, Horsdal HT, Lally J, MacCabe JH, Murray RM, Gasse C, Wimberley T.

Schizophr Res. 2018 Jul;197:294-297. doi: 10.1016/j.schres.2018.02.017. Epub 2018 Feb 19.

PMID:
29472163

Supplemental Content

Loading ...
Support Center